This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ng, P. C. Articles by Chan, D. C. F. Search for Related Content PubMed PubMed Citation Articles by Ng, P. C. Articles by Chan, D. C. F.

Pituitary-Adrenal Suppression and Recovery in Preterm Very Low Birth Weight Infants after Dexamethasone Treatment for Bronchopulmonary Dysplasia

Departments of Pediatrics and Chemical Pathology (C.W.K.L., D.C.F.C.), Prince of Wales Hospital, The Chinese University of Hong Kong; and the Department of Mathematics, The Hong Kong University of Science and Technology (M.Y.W.), Hong Kong

Address all correspondence and requests for reprints to: Dr. P. C. Ng, Department of Pediatrics, Level 6, Clinical Sciences Building, Prince of Wales Hospital, Shatin, New Territories, Hong Kong.

High dose dexamethasone is frequently used for the treatment of neonatal respiratory conditions and to facilitate weaning from mechanical ventilation in preterm, very low birth weight infants. However, very little is known about the severity, site, and duration of steroid-induced hypothalamic-pituitary-adrenal axis suppression in this category of patients.

Twenty-three preterm, very low birth weight infants who received a full 3-week dose-tapering course of dexamethasone were prospectively studied, with a human CRH stimulation test performed at three different times: before the start of steroid treatment (week 0), immediately after the course (week 3), and 4 weeks after stopping dexamethasone (week 7). Plasma ACTH and serum cortisol concentrations were measured at 0 (baseline), 15, 30, and 60 min. Immediately after the steroid course (week 3), both basal and poststimulation plasma ACTH and serum cortisol concentrations were markedly suppressed. The hormone concentrations at 0, 15, 30, and 60 min in week 3 were significantly lower than their corresponding levels in week 0 (P < 0.0001 for both ACTH and cortisol) and week 7 (P < 0.0001 and P < 0.005 for ACTH and cortisol, respectively). In contrast, when the hormone levels in week 7 were compared to their corresponding concentrations in week 0, only the 60 min serum cortisol concentration in week 7 was significantly lower (P = 0.02).

The currently used dosage of dexamethasone caused severe pituitary-adrenal suppression immediately after treatment, but substantial recovery of the endocrine axis was observed 4 weeks after discontinuation of therapy. Although the recovery appeared to be earlier with the pituitary center, both pituitary and adrenal glands were capable of mounting a biochemically adequate response to exogenous human CRH stimulation at this stage. Steroid replacement therapy may be desirable at a time of stress in the immediate posttreatment period, but it would seem unnecessary 1 month after stopping dexamethasone treatment.

This article has been cited by other articles:

				P. Nykanen, T. Raivio, K. Heinonen, O. A Janne, and R. Voutilainen Circulating glucocorticoid bioactivity and serum cortisol concentrations in premature infants: the influence of exogenous glucocorticoids and clinical factors Eur. J. Endocrinol., May 1, 2007; 156(5): 577 - 583. [Abstract] [Full Text] [PDF]

				E S Shinwell, L Lerner-Geva, A Lusky, B Reichman, and in collaboration with the Israel Neonatal Network Less postnatal steroids, more bronchopulmonary dysplasia: a population-based study in very low birthweight infants Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2007; 92(1): F30 - F33. [Abstract] [Full Text] [PDF]

				P C Ng, C H Lee, C W K Lam, K C Ma, I H S Chan, E Wong, and T F Fok Early pituitary-adrenal response and respiratory outcomes in preterm infants Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2004; 89(2): F127 - F130. [Abstract] [Full Text] [PDF]

				H. M. Hammon, S. N. Sauter, M. Reist, Y. Zbinden, C. Philipona, C. Morel, and J. W. Blum Dexamethasone and colostrum feeding affect hepatic gluconeogenic enzymes differently in neonatal calves J Anim Sci, December 1, 2003; 81(12): 3095 - 3106. [Abstract] [Full Text] [PDF]

				Statement on the Care of the Child with Chronic Lung Disease of Infancy and Childhood Am. J. Respir. Crit. Care Med., August 1, 2003; 168(3): 356 - 396. [Full Text] [PDF]

				B. A. Banks Postnatal Dexamethasone for Bronchopulmonary Dysplasia: A Systematic Review and Meta-analysis of 20 Years of Clinical Trials NeoReviews, February 1, 2002; 3(2): e24 - 34. [Full Text]

				P C Ng The fetal and neonatal hypothalamic-pituitary-adrenal axis Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2000; 82(3): 250F - 254. [Full Text]

				P C Ng, G W K Wong, C W K Lam, C H Lee, T F Fok, M Y Wong, and K C Ma Effect of multiple courses of antenatal corticosteroids on pituitary-adrenal function in preterm infants Arch. Dis. Child. Fetal Neonatal Ed., May 1, 1999; 80(3): 213F - 216. [Abstract] [Full Text]

				P. C. Ng, T. F. Fok, G. W. K. Wong, C. W. K. Lam, C. H. Lee, M. Y. Wong, K. Lam, and K. C. Ma Pituitary-Adrenal Suppression in Preterm, Very Low Birth Weight Infants after Inhaled Fluticasone Propionate Treatment J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2390 - 2393. [Abstract] [Full Text]